Grupo Brasileiro de Mieloma | Real- world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara- VTd) induction and lenalidomide maintenance in transplant- eligible multiple myeloma - Grupo Brasileiro de Mieloma

contato@gbram.org

LReal- world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara- VTd) induction and lenalidomide maintenance in transplant- eligible multiple myeloma

19/05/2026